Clinical trial
Fourth BNT162b2 COVID-19 Vaccine Dose - the Sheba HCW Cohort
NCT05231005 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fourth BNT162b2 COVID-19 Vaccine Dose - the Sheba HCW Cohort
- Lead sponsor
- Sheba Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 27, 2021
- Completion date
- June 26, 2024
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19 pandemic